Gilead Sciences will invest $275m in return for a 49.9% stake as part of a deal that could see it purchase the cancer immunotherapy developer outright.

Sana Biotechnology has closed its first round at more than $700m after investors including GV swung behind its vision to commercialise cell therapies.

The kidney care services provider has now collected more than $105m to date, Optum Ventures co-leading a round also featuring Blue Venture Fund.

Northwestern Mutual and RBC invested in a $62.5m round for eal estate services platform Ojo that funded the acquisition of Mitsui Fudosan-backed Movoto.

Gilead Sciences will invest $275m for a 49.9% stake in the UofT and UCSF-linked company as part of a $1.47bn deal to potentially purchase Pionyr outright.

GV and Citi Ventures have helped the customer service platform developer nearly double its total funding to $100m by returning for a series C round led by Sapphire Ventures.

The VaynerMedia-backed online design platform developer was valued at $6bn in a $60m round co-led by Blackbird Ventures and Sequoia China.

Intel Capital led a $40m round for the data management software provider while Dell Technologies Capital and Citi Ventures also invested.

Citi Ventures and existing backer Slack Fund helped the communications API provider take its overall funding to more than $55m.

The Lowe's-backed home finance provider increased its overall equity funding to more than $22m in a second series A tranche led by Omers Ventures.